BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) was the target of a significant drop in short interest in the month of August. As of August 31st, there was short interest totaling 30,094 shares, a drop of 62.5% from the August 15th total of 80,226 shares. Based on an average daily volume of 170,903 shares, the days-to-cover ratio is presently 0.2 days.
Institutional Investors Weigh In On BlackRock Health Sciences Term Trust
Large investors have recently bought and sold shares of the company. Saba Capital Management L.P. acquired a new position in BlackRock Health Sciences Term Trust during the first quarter worth about $10,907,000. Calamos Advisors LLC acquired a new stake in BlackRock Health Sciences Term Trust in the 1st quarter valued at about $740,000. Lazard Asset Management LLC raised its holdings in BlackRock Health Sciences Term Trust by 64.2% in the 1st quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock valued at $8,926,000 after acquiring an additional 243,054 shares during the last quarter. Rivernorth Capital Management LLC lifted its stake in BlackRock Health Sciences Term Trust by 24.8% in the 1st quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock worth $11,620,000 after purchasing an additional 160,629 shares in the last quarter. Finally, Kestra Advisory Services LLC lifted its stake in BlackRock Health Sciences Term Trust by 3,561.5% in the 1st quarter. Kestra Advisory Services LLC now owns 62,246 shares of the company’s stock worth $894,000 after purchasing an additional 60,546 shares in the last quarter.
BlackRock Health Sciences Term Trust Stock Down 0.5%
Shares of BMEZ stock traded down $0.09 on Friday, reaching $16.47. 173,653 shares of the company were exchanged, compared to its average volume of 210,089. BlackRock Health Sciences Term Trust has a 1 year low of $13.70 and a 1 year high of $17.25. The business has a 50-day moving average price of $16.07 and a 200 day moving average price of $15.00.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
